Literature DB >> 6252153

Cefotaxime in the treatment of lower respiratory tract infections.

P Hänninen, A Toivanen, O Vainio, P Toivanen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6252153     DOI： 10.1093/jac/6.suppl_a.181

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  [Therapy with cefotaxime-cefotaxime/ticarcillin for bronchopulmonary infections in patients under intensive care. (author's transl)].

Authors:  C D Schwigon
Journal:  Infection       Date:  1982       Impact factor: 3.553

2.  Respiratory superinfections after the use of third-generation cephem antibiotics.

Authors:  A Saito; K Mori; Y Shigeno; K Yamaguchi; K Hara
Journal:  Infection       Date:  1985       Impact factor: 3.553

3.  Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.

Authors:  H Lode; P D Glatzel
Journal:  Infection       Date:  1985       Impact factor: 3.553

Review 4.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.